Vantage Financial Partners (Illinois)’s Eli Lilly LLY Stock Holding History

Vantage Financial Partners (Illinois)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$602K	Hold	665	–	–	0.15%	66
2024 Q1	$517K	Sell	665 -70	-10%	-$49.8K	0.13%	73
2023 Q4	$428K	Sell	735 -275	-27%	-$161K	0.13%	78
2023 Q3	$543K	Sell	1,010 -25	-2%	-$12.9K	0.31%	55
2023 Q2	$485K	Sell	1,035 -50	-5%	-$21K	0.27%	57
2023 Q1	$373K	Buy	1,085 +150	+16%	+$50.6K	0.22%	70
2022 Q4	$342K	Hold	935	–	–	0.2%	77
2022 Q3	$302K	Buy	+935	New	+$296K	0.2%	73
2019 Q1	–	Sell	-6,000	Closed	-$694K	–	83
2018 Q4	$694K	Hold	6,000	–	–	0.51%	32
2018 Q3	$644K	Hold	6,000	–	–	0.41%	36
2018 Q2	$512K	Hold	6,000	–	–	0.34%	44
2018 Q1	$464K	Hold	6,000	–	–	0.32%	46
2017 Q4	$506K	Buy	+6,000	New	+$511K	0.33%	41
2017 Q3	–	Sell	-6,000	Closed	-$494K	–	67
2017 Q2	$494K	Buy	+6,000	New	+$490K	0.35%	41
2017 Q1	–	Sell	-3,800	Closed	-$279K	–	62
2016 Q4	$279K	Buy	+3,800	New	+$283K	0.25%	41

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vantage Financial Partners (Illinois)'s LLY Position: Q2 2024 in Review

Vantage Financial Partners (Illinois) held its Eli Lilly (LLY) position steady in Q2 2024 at 665 shares worth $602K. The position accounts for 0.15% of the portfolio, ranked #66.

Vantage Financial Partners (Illinois) first reported a position in LLY in Q4 2016 and has held it in 15 quarters since. The position peaked at $694K in Q4 2018. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

Vantage Financial Partners (Illinois) held 665 shares of Eli Lilly worth $602K as of Q2 2024.
Vantage Financial Partners (Illinois) left its Eli Lilly share count unchanged in Q2 2024.
Eli Lilly made up 0.15% of Vantage Financial Partners (Illinois)'s portfolio in Q2 2024, its #66 holding.
Vantage Financial Partners (Illinois) first reported a position in Eli Lilly in Q4 2016 and has held it in 15 quarters since.
Vantage Financial Partners (Illinois)'s Eli Lilly position peaked at $694K in Q4 2018.
3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Vantage Financial Partners (Illinois)'s 13F filing for Q2 2024, filed 14 Aug 2024.